A novel use of an in vitro method to predict the in vivo stability of block copolymer based nano-containers.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Controlled Release

• Publication date

  2007-09-11

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1016/J.JCONREL.2007.06.008PMID 17644207
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Polymeric micellar delivery reduces kidney distribution and nephrotoxic effects of Cyclosporine A after multiple dosing.

  2008cited by this paper
• Encapsulation of hydrophobic drugs in polymeric micelles through co-solvent evaporation: the effect of solvent composition on micellar properties and drug loading.

  2007cited by this paper
• Polymeric micelles for drug delivery

  2006cited by this paper
• In vitro release of the mTOR inhibitor rapamycin from poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles.

  2006cited by this paper
• The effect of increased lipoprotein levels on the pharmacokinetics of cyclosporine A in the laboratory rat

  2006cited by this paper
• Pharmacokinetics of Amiodarone in hyperlipidemic and simulated high fat‐meal rat models

  2005cited by this paper
• Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution.

  2005cited by this paper
• Poly(ethylene oxide)-b-poly(N-isopropylacrylamide) nanoparticles with cross-linked cores as drug carriers

  2005cited by this paper
• Micelles of methoxy poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine A.

  2005cited by this paper
• Micellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin delivery.

  2004cited by this paper
• Micellar carriers based on block copolymers of poly(ε-caprolactone) and poly(ethylene glycol) for doxorubicin delivery

  2004cited by this paper
• Core-cross-linked polymeric micelles as paclitaxel carriers.

  2004cited by this paper
• Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice.

  2003cited by this paper
• Differential gene expression profile between PC-14 cells treated with free cisplatin and cisplatin-incorporated polymeric micelles.

  2003cited by this paper
• Pharmaceutical and Biomedical Differences between Micellar Doxorubicin (NK911) and Liposomal Doxorubicin (Doxil)

  2002cited by this paper
• The influence of lipids on stereoselective pharmacokinetics of halofantrine: Important implications in food-effect studies involving drugs that bind to lipoproteins.

  2002cited by this paper
• Stereoselective halofantrine and desbutylhalofantrine disposition in the rat: cardiac and plasma concentrations and plasma protein binding

  2002cited by this paper
• High-performance liquid chromatographic analysis of cyclosporin A in rat blood and liver using a commercially available internal standard.

  2002cited by this paper
• Biodegradable polylactide/poly(ethylene glycol)/polylactide triblock copolymer micelles as anticancer drug carriers

  2001cited by this paper
• Micelles self-assembled from poly(ethylene oxide)-block-poly(N-hexyl stearate L-aspartamide) by a solvent evaporation method: effect on the solubilization and haemolytic activity of amphotericin B.

  2001cited by this paper
• Dose-dependent pharmacokinetics of cyclosporin A in rats: events in tissues.

  2000cited by this paper
• Methotrexate Esters of Poly(Ethylene Oxide)-Block-Poly(2-Hydroxyethyl-L-Aspartamide). Part I: Effects of the Level of Methotrexate Conjugation on the Stability of Micelles and on Drug Release

  2000cited by this paper
• Determination of the free fraction and relative free fraction of drugs strongly bound to plasma proteins.

  2000cited by this paper
• Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance.

  2000cited by this paper
• Clonazepam release from poly(DL-lactide-co-glycolide) nanoparticles prepared by dialysis method

  1998cited by this paper
• Clonazepam release from core-shell type nanoparticles in vitro.

  1998cited by this paper
• Physical Entrapment of Adriamycin in AB Block Copolymer Micelles

  1995cited by this paper
• Block copolymer micelles as long-circulating drug vehicles

  1995cited by this paper
• Assessment of cyclosporine A interactions with human plasma lipoproteins in vitro and in vivo in the rat.

  1990cited by this paper

• In situ generation of hydroperoxide-rich-peptide-based nano-assemblies for self-amplified magnetic resonance imaging-guided synergistic tumor chemo/chemodynamic/ferroptotic therapy.

  2025cites this paper
• Multimodal Theranostic Nanoparticles for Necrosis Targeting, Fluorescence/SPECT Imaging, and Radiotherapy of Residual Tumors after Hepatocellular Carcinoma Ablation.

  2024cites this paper
• Pharmacokinetic and Tissue Distribution of Orally Administered Cyclosporine A-Loaded poly(ethylene oxide)-block-Poly(ε-caprolactone) Micelles versus Sandimmune® in Rats

  2021cites this paper
• Nanoscale platform for delivery of active IRINOX to combat pancreatic cancer.

  2020cites this paper
• Biodegradable hypericin-containing nanoparticles for necrosis targeting and fluorescence imaging.

  2020cites this paper
• Pharmacokinetics of Orally Administered Poly(Ethylene Oxide)-block-Poly(ε-Caprolactone) Micelles of Cyclosporine A in Rats: Comparison with Neoral®.

  2018cites this paper
• Toxicity evaluation of methoxy poly(ethylene oxide)-block-poly(ε-caprolactone) polymeric micelles following multiple oral and intraperitoneal administration to rats

  2017cites this paper
• PEG‐PCL‐based nanomedicines: A biodegradable drug delivery system and its application

  2017cites this paper
• Comparative Study of Different Nano-Formulations of Curcumin for Reversal of Doxorubicin Resistance in K562R Cells

  2017cites this paper
• Tuning polypeptide‐based micellar carrier for efficient combination therapy of ErbB2‐positive breast cancer

  2017cites this paper
• Microfluidic synthesis of block copolymer nanoparticles for drug delivery

  2016cites this paper
• Microfluidic synthesis of dye-loaded polycaprolactone-block-poly(ethylene oxide) nanoparticles: Insights into flow-directed loading and in vitro release for drug delivery.

  2016cites this paper
• Polymeric Nanogel for Non-covalent Hydrophobic Drug Encapsulation

  2015cites this paper
• Peripherally Cross-Linking the Shell of Core-Shell Polymer Micelles Decreases Premature Release of Physically Loaded Combretastatin A4 in Whole Blood and Increases its Mean Residence Time and Subsequent Potency Against Primary Murine Breast Tumors After IV Administration

  2014influential citation
• Poly(ethylene glycol)-block-poly(ε-caprolactone) nanomicelles for the solubilization and enhancement of antifungal activity of sertaconazole.

  2014cites this paper
• Premature drug release of polymeric micelles and its effects on tumor targeting.

  2013cites this paper
• Polymeric micelles for solubilization and targeting of hydrophobic drugs

  2013cites this paper
• Comparative Investigations on In Vitro Serum Stability of Polymeric Micelle Formulations

  2012cites this paper
• Encapsulation of P-glycoprotein inhibitors by polymeric micelles can reduce their pharmacokinetic interactions with doxorubicin.

  2012cites this paper
• Analysis of immediate stress mechanisms upon injection of polymeric micelles and related colloidal drug carriers: implications on drug targeting.

  2012cites this paper
• Amphiphilic block co-polymers: preparation and application in nanodrug and gene delivery.

  2012cites this paper
• Cyclosporine A-loaded and stem cell-seeded electrospun nanofibers for cell-based therapy and local immunosuppression.

  2011cites this paper
• Controlled Release of Cyclosporine a from Biodegradable Amphiphilic Diblock Copolymer Sol-gel Drug Delivery System

  2011cites this paper
• Development of a polymeric micellar formulation for valspodar and assessment of its pharmacokinetics in rat.

  2010cites this paper
• A poly(γ-glutamic acid)–amphiphile complex as a novel nanovehicle for drug delivery system

  2010cites this paper
• Pharmacokinetics of PSC 833 (valspodar) in its Cremophor EL formulation in rat

  2010cites this paper
• Disposition of Drugs in Block Copolymer Micelle Delivery Systems

  2008cites this paper
• Synthesis of poly(ethylene oxide)-based thermoresponsive block copolymers by RAFT radical polymerization and their uses for preparation of gold nanoparticles

  2008cites this paper